These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5288233)

  • 21. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
    Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
    [No Abstract]   [Full Text] [Related]  

  • 22. Endometrial morphology of women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Luukkainen T; Arko H
    Fertil Steril; 1978 Apr; 29(4):397-401. PubMed ID: 648644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norgestimate: overview of a monophasic formulation.
    Anderson FD; Gillmer MD
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():126-32. PubMed ID: 8260971
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of two different combinations of ethinyl estradiol and levonorgestrel on hepatic functions.
    Mandal B; Maity CR
    Indian J Exp Biol; 1985 Apr; 23(4):230-2. PubMed ID: 3935573
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of several estrogenic compounds on serum corticosteroid-binding globulin (CBG) and the estrogen thresholds for increasing CBG (author's transl)].
    Kawagoe S; Hiroi M
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):666-75. PubMed ID: 211055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A regimen for fertility control with a cyclic progestogen.
    Roland M; Leisten D; Caruso LJ
    Obstet Gynecol; 1973 Apr; 41(4):595-601. PubMed ID: 4696978
    [No Abstract]   [Full Text] [Related]  

  • 27. Examinations with Anteovin, a biphasic contraceptive.
    Adám J; Garamvölgyi G
    Ther Hung; 1984; 32(4):176-80. PubMed ID: 6571205
    [No Abstract]   [Full Text] [Related]  

  • 28. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 29. Five years of fertility control with microdose norgestrel: An updated clinical review.
    Korba VD; Paulson SR
    J Reprod Med; 1974 Aug; 13(2):71-5. PubMed ID: 4844517
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical observations with Rigevidon.
    Bálint S
    Ther Hung; 1980; 28(2):75-8. PubMed ID: 7466718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of an oral contraceptive on serum phosphohexose isomerase activity.
    Gupta U; Khuteta KP; Gupta RC
    Indian J Physiol Pharmacol; 1983; 27(3):253-4. PubMed ID: 6668056
    [No Abstract]   [Full Text] [Related]  

  • 32. Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo.
    Anderson FD; Feldman R; Reape KZ
    Contraception; 2008 Feb; 77(2):91-6. PubMed ID: 18226671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormonal contraceptives in female rowers].
    Lisý Z
    Cas Lek Cesk; 1984 Aug; 123(35):1086-90. PubMed ID: 6498900
    [No Abstract]   [Full Text] [Related]  

  • 34. A metabolic balance study of the effects of an oral steroid contraceptive on weight and body composition.
    Kudzma DJ; Bradley EM; Goldzieher JW
    Contraception; 1972 Jan; 5(1):31-7. PubMed ID: 4650644
    [No Abstract]   [Full Text] [Related]  

  • 35. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles.
    Woutersz TB
    J Reprod Med; 1981 Dec; 26(12):615-20. PubMed ID: 7033528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
    Janaud A; Rouffy J; Upmalis D; Dain MP
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():114-6. PubMed ID: 8260968
    [No Abstract]   [Full Text] [Related]  

  • 38. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
    Andolsek KM; Burkman RT; Kafrissen ME; Olson W; Osterman J
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():122-5. PubMed ID: 8260970
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative clinical and morphological studies of 2 oral contraceptives containing DL-norgestrel or D-norgestre].
    Brosens I; Van Assche A; Wijnants P
    Geburtshilfe Frauenheilkd; 1971 Mar; 31(3):251-7. PubMed ID: 5550233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.